Episode Details

Back to Episodes
Dimethyl fumarate (Tecfidera) and Diroximel fumarate (Vumerity) for relapsing remitting multiple sclerosis

Dimethyl fumarate (Tecfidera) and Diroximel fumarate (Vumerity) for relapsing remitting multiple sclerosis

Season 1 Episode 62 Published 2 years, 2 months ago
Description

Tecfidera and Vumerity, the fumarates kick-off the informative series about immunotherapy for multiple sclerosis.

You can find the full article to read on my blog: https://ms-perspektive.com/62-fumarates

Tecfidera and Vumerity, the fumarates, kick off the series on the approved disease-modifying therapies for MS. I am trying to give a good overview, but it does not claim to be complete information. The order is simple. It starts with a rather broad mechanism of action, which works for a good proportion of those affected, through to the increasingly specific mechanisms of action, which work for the majority of all MS patients. Detailed advice can only be given by MS specialists and cannot be provided by me.

"},"minimize_box":"yes","minimized_on":"tablet","hierarchical_view":"yes","min_height":{"unit":"px","size":"","sizes":[]},"min_height_tablet":{"unit":"px","size":"","sizes":[]},"min_height_mobile":{"unit":"px","size":"","sizes":[]}}" data-widget_type="table-of-contents.default"> Table of Contents Sources

I used the following sources to create the content:

Listen Now